These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Medical tretment and mortality in cardiogenic shock. Metaraminol compared with combined phentolamine and norepinephrine. Glucagon therapy. Takkunen J, Oilinki O, Huhti E, Vuopala U, Koivisto O. Acta Med Scand; 1972 Sep; 192(3):165-70. PubMed ID: 5055261 [No Abstract] [Full Text] [Related]
14. Clinical appraisal of shock following acute myocardial infarction. Mir MA, Rees S, Yahya AM, Williams JD, Reeves TL. Cardiology; 1974 Oct; 59(2):69-82. PubMed ID: 4434361 [No Abstract] [Full Text] [Related]
15. [Cardiovascular effects of hydroxytyramine (dopamine) and its importance in the treatment of cardiogenic shock in myocardial infarct. I. Clinical studies on normal persons]. Döring D, Trenckmann H, Urbaszek W. Z Gesamte Inn Med; 1969 Dec 15; 24(24):881-6. PubMed ID: 5365454 [No Abstract] [Full Text] [Related]
16. [Studies on the therapy of shock in acute myocardial infarct]. Bravi A, Volpi G, Pupillo A, De Luca FM, Tuveri A. Boll Soc Ital Cardiol; 1973 Dec 15; 18(2):139-46. PubMed ID: 4807052 [No Abstract] [Full Text] [Related]
17. Drugs for shock following acute myocardial infarction. Walters MB. Can Med Assoc J; 1965 Oct 23; 93(17):933-4. PubMed ID: 5829411 [No Abstract] [Full Text] [Related]